Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Retained Earnings: 2019-2022

Historic Retained Earnings for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to -$1.1 billion.

  • ADC Therapeutics' Retained Earnings fell 16.90% to -$1.2 billion in Q3 2023 from the same period last year, while for Sep 2023 it was -$1.2 billion, marking a year-over-year decrease of 16.90%. This contributed to the annual value of -$1.1 billion for FY2022, which is 18.44% down from last year.
  • Latest data reveals that ADC Therapeutics reported Retained Earnings of -$1.1 billion as of FY2022, which was down 18.44% from -$924.9 million recorded in FY2021.
  • Over the past 5 years, ADC Therapeutics' Retained Earnings peaked at -$448.6 million during FY2019, and registered a low of -$1.1 billion during FY2022.
  • Over the past 2 years, ADC Therapeutics' median Retained Earnings value was -$1.0 billion (recorded in 2021), while the average stood at -$1.0 billion.
  • Data for ADC Therapeutics' Retained Earnings shows a maximum YoY dropped of 18.44% (in 2022) over the last 5 years.
  • ADC Therapeutics' Retained Earnings (Yearly) stood at -$448.6 million in 2019, then reached -$924.9 million in 2021, then fell by 18.44% to -$1.1 billion in 2022.